MXPA03000843A - Una proteina humana de disintegrina. - Google Patents

Una proteina humana de disintegrina.

Info

Publication number
MXPA03000843A
MXPA03000843A MXPA03000843A MXPA03000843A MXPA03000843A MX PA03000843 A MXPA03000843 A MX PA03000843A MX PA03000843 A MXPA03000843 A MX PA03000843A MX PA03000843 A MXPA03000843 A MX PA03000843A MX PA03000843 A MXPA03000843 A MX PA03000843A
Authority
MX
Mexico
Prior art keywords
human disintegrin
disintegrin
disintegrin protein
methods
protein
Prior art date
Application number
MXPA03000843A
Other languages
English (en)
Inventor
Robert F Dubose
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of MXPA03000843A publication Critical patent/MXPA03000843A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
    • G16B15/30—Drug targeting using structural data; Docking or binding prediction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Physics & Mathematics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Theoretical Computer Science (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)

Abstract

Se proporciona un nuevo polipeptido de disintegrina, metodos para hacer dichos polipeptidos, y metodos para utilizar los para el tratamiento de trastornos y condiciones asociadas con disintegrina y para identificar agentes que modulan actividades del polipeptido de metaloproteinasa-disintegrina.
MXPA03000843A 2000-07-28 2001-07-27 Una proteina humana de disintegrina. MXPA03000843A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22183800P 2000-07-28 2000-07-28
US28255001P 2001-04-09 2001-04-09
PCT/US2001/023709 WO2002010405A2 (en) 2000-07-28 2001-07-27 A human disintegrin protein

Publications (1)

Publication Number Publication Date
MXPA03000843A true MXPA03000843A (es) 2004-04-05

Family

ID=26916195

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03000843A MXPA03000843A (es) 2000-07-28 2001-07-27 Una proteina humana de disintegrina.

Country Status (9)

Country Link
EP (1) EP1305434B1 (es)
JP (1) JP2004504845A (es)
AT (1) ATE356877T1 (es)
AU (2) AU2001280843B2 (es)
CA (1) CA2415433A1 (es)
DE (1) DE60127264T2 (es)
ES (1) ES2283424T3 (es)
MX (1) MXPA03000843A (es)
WO (1) WO2002010405A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113286606A (zh) * 2018-01-31 2021-08-20 维拉疗法有限公司 抑制adam 9生物活性的方法和组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001008396A1 (en) * 1999-07-23 2001-02-01 Telemetry Technologies, Inc. System and method for a virtual network operations center
US6728770B1 (en) * 1999-12-03 2004-04-27 Storage Technology Corporation Method and apparatus for workload balancing along multiple communication paths to a plurality of devices
CA2399913A1 (en) * 2000-03-03 2001-09-13 Human Genome Sciences, Inc. Adam polynucleotides, polypeptides, and antibodies
AU6531101A (en) * 2000-06-02 2001-12-17 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same

Also Published As

Publication number Publication date
CA2415433A1 (en) 2002-02-07
WO2002010405A2 (en) 2002-02-07
JP2004504845A (ja) 2004-02-19
ES2283424T3 (es) 2007-11-01
AU8084301A (en) 2002-02-13
DE60127264T2 (de) 2007-12-20
EP1305434A2 (en) 2003-05-02
DE60127264D1 (de) 2007-04-26
EP1305434B1 (en) 2007-03-14
ATE356877T1 (de) 2007-04-15
AU2001280843B2 (en) 2006-12-07
WO2002010405A3 (en) 2003-01-23

Similar Documents

Publication Publication Date Title
PL377553A1 (pl) Peptydy oraz pokrewne cząsteczki modulujące aktywność czynnika wzrostu nerwów
NZ506783A (en) Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities
DE60118544D1 (de) Methoden und zusammensetzungen zur modulation der aktivität der alpha-adrenergen rezeptoren
AP2000001811A0 (en) Modified vitamin K- dependent polypeptides.
DK0907631T3 (da) Uorganiske ionreceptoraktive forbindelser
AU2210400A (en) Method of using a cyclooxygenase-2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia
IL125711A0 (en) Human metabotropic glutamate receptor
GB9907429D0 (en) Modulation of C-fibre activity
BG100981A (en) Methods of producing effective recombinant serine inhibitors and uses of these ihibitors
BR9507237A (pt) Protease altamente alcalina e sua aplicação
HK1029936A1 (en) Quinoline-containing alpha-ketoamide cysteine and serine protease inhibitors
PL329109A1 (en) Method of modulating the synthesis of melanin
HUP0004544A2 (hu) Angiotenzin-átalakító enzim inhibitora és diuretikum kombinációjának alkalmazása mikrokeringési rendellenességek kezelésére szolgáló gyógyászati készítmény előállítására
EP0975353A4 (en) PEPTIDYL-2-AMINO-1HYDROXYALKANESULPHONIC ACIDS AS CYSTEIN PROTEASE INHIBITORS
AU5338401A (en) Methods and compositions for modulating alpha adrenergic receptor activity
DE60128701D1 (en) Claudin polypeptide
HUP0104022A2 (hu) Béta-szekretáz típusú aktivitással rendelkező polipeptidek
MXPA03003207A (es) Materiales y metodos para modular la actividad de union de ligando/enzimatica de proteinas alfa/¦ que contienen un sitio regulador alosterico.
DE60134230D1 (de) Substraten und nachweise zur wirksamkeit von beta-secretase
AU3175197A (en) Recombinant blood-coagulation proteases
AU8084301A (en) A human disintegrin protein
GB9925005D0 (en) The treatment of wounds
WO2002010406A3 (en) Metalloproteinase-disintegrin polypeptides and methods of making and use thereof
AR033476A1 (es) Leche tratada resistente a la coagulacion acida para incrementar la biodisponibilidad de calcio, metodo para obtenerla, productos en base a leche elaborados con dicha leche tratada y metodos de elaboracion
GR3015924T3 (en) Catabolic enzymes for the induction of the tumour necrosis factor (TNF).

Legal Events

Date Code Title Description
FA Abandonment or withdrawal